Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali

基于遗传的个人预测模型的功效预测方法

基本信息

  • 批准号:
    7828231
  • 负责人:
  • 金额:
    $ 33.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-12-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The collection of newly discovered clinically valuable genetic tests is far outpacing our ability to use clinical trials to determine their clinical efficacy and determine which of the collection of tests and associated algorithms are best suited for any given clinical setting. For example, a review of the literature demonstrates that at least 35 published algorithms for the prediction of therapeutic warfarin dosing have been published in the past ten years, nine of which include genotype data (unpublished review). Expenditures to determine the most clinical useful of these algorithms include a total of 19 clinical trials (clinicaltrials.gov, accessed Feb, 2008) Compounding this complexity and adding to the delay of the successful medical use of the rapidly expanding collection of clinically valuable genetic discoveries is the lack of clinical and biomedical informatic methods, tools and infrastructure required to facilitate the successful translation of the discoveries to practical clinical use. Efforts to translate important biomedical informatics methods, tools and processes required to implement important new genetic discoveries in the clinical setting are severely hindered by regulatory, technical and validation barriers not easily resolved in the current clinical-research or clinical enterprise environments. This proposal will test an environment and methodology that creates clinical avatars with data statistically consistent with actual patient electronic medical records. Once created, these clinical avatar medical records will be used to conduct insilico experiments to compare genetic- based algorithms and their predicted value in the clinical setting. We will develop and test the methodology and create the applications by conducting a series of clinical avatar simulations and subsequent analysis of genetic-based warfarin dosing prediction. Once developed, we will conduct a series of insilico clinical trials comparing various clinical and genetic factors to demonstrate the efficacy of the warfarin dosing algorithms. This work is representative of similar projects that may be designed to test other personalized medicine devices such as genetic tests used to quantify risk to cancers, pharmacogenetic problems, and other FDA labeled "IVDMIA" devices (e.g. Genetic Health's Oncotype DX(R)) projected to improve predictive and preventive personalized medicine.
描述(由申请人提供):新发现的具有临床价值的基因测试的集合远远超过了我们使用临床试验来确定其临床有效性并确定哪些测试集合和相关算法最适合任何给定临床设置的能力。例如,对文献的回顾表明,在过去的十年中,至少有35种已发表的华法林治疗性剂量预测算法被发表,其中9种算法包含了基因数据(未发表的综述)。确定这些算法中最有临床用途的支出包括总共19项临床试验(Clinicaltrials.gov,2008年2月访问)。使这种复杂性变得更加复杂的是,缺乏将这些发现成功转化为临床应用所需的临床和生物医学信息学方法、工具和基础设施,这加剧了迅速扩大的临床有价值的基因发现集合的成功医疗应用的延迟。将重要的生物医学信息学方法、工具和过程转化为在临床环境中实施重要的新基因发现所需的努力,受到监管、技术和验证障碍的严重阻碍,这些障碍在当前的临床研究或临床企业环境中不易解决。这项提案将测试创建临床化身的环境和方法,这些化身的数据在统计上与实际患者的电子病历一致。一旦创建,这些临床化身医疗记录将被用于进行Insilo实验,以比较基于遗传的算法及其在临床环境中的预测值。我们将开发和测试该方法,并通过进行一系列临床化身模拟和随后基于遗传的华法林剂量预测分析来创建应用程序。一旦开发出来,我们将进行一系列Insilo临床试验,比较各种临床和遗传因素,以证明华法林剂量算法的有效性。这项工作是类似项目的代表,这些项目可能旨在测试其他个性化医疗设备,例如用于量化癌症风险的基因测试、药物遗传学问题,以及其他FDA标记的“IVDMIA”设备(例如,Genetic Health的Oncotype DX(R)),预计将改善预测性和预防性个性化医疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter J. Tonellato其他文献

Breast cancer risk assessment based on a predictive model: evaluation of risk factors among Japanese women
  • DOI:
    10.1186/s12885-025-13556-8
  • 发表时间:
    2025-02-05
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Michiyo Yamada;Takashi Chishima;Takashi Ishikawa;Kazutaka Narui;Sadatoshi Sugae;Peter J. Tonellato;Itaru Endo
  • 通讯作者:
    Itaru Endo

Peter J. Tonellato的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter J. Tonellato', 18)}}的其他基金

Predictive optimal anticlotting treatment for segmented patient populations
针对细分患者群体的预测性最佳抗凝血治疗
  • 批准号:
    8723295
  • 财政年份:
    2013
  • 资助金额:
    $ 33.9万
  • 项目类别:
PREDICTIVE OPTIMAL ANTICLOTTING TREATMENT FOR SEGMENTED PATIENT POPULATIONS
针对细分患者群体的预测性最佳抗凝血治疗
  • 批准号:
    9678754
  • 财政年份:
    2013
  • 资助金额:
    $ 33.9万
  • 项目类别:
Predictive optimal anticlotting treatment for segmented patient populations
针对细分患者群体的预测性最佳抗凝血治疗
  • 批准号:
    8913774
  • 财政年份:
    2013
  • 资助金额:
    $ 33.9万
  • 项目类别:
Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali
基于遗传的个人预测模型的功效预测方法
  • 批准号:
    8065244
  • 财政年份:
    2010
  • 资助金额:
    $ 33.9万
  • 项目类别:
Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali
基于遗传的个人预测模型的功效预测方法
  • 批准号:
    8119797
  • 财政年份:
    2010
  • 资助金额:
    $ 33.9万
  • 项目类别:
Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali
基于遗传的个人预测模型的功效预测方法
  • 批准号:
    7726391
  • 财政年份:
    2009
  • 资助金额:
    $ 33.9万
  • 项目类别:
CORE--BIOINFORMATICS
核心--生物信息学
  • 批准号:
    7013119
  • 财政年份:
    2005
  • 资助金额:
    $ 33.9万
  • 项目类别:
CORE--BIOINFORMATICS
核心--生物信息学
  • 批准号:
    6565005
  • 财政年份:
    2002
  • 资助金额:
    $ 33.9万
  • 项目类别:
CORE--INFORMATICS AND COMPUTATIONAL RESOURCE
核心--信息学和计算资源
  • 批准号:
    6302385
  • 财政年份:
    2000
  • 资助金额:
    $ 33.9万
  • 项目类别:
CORE--INFORMATICS AND COMPUTATIONAL RESOURCE
核心--信息学和计算资源
  • 批准号:
    6110544
  • 财政年份:
    1999
  • 资助金额:
    $ 33.9万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.9万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 33.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了